RAC 1.81% $1.63 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-7

  1. 8,506 Posts.
    lightbulb Created with Sketch. 1397
    Very true John.

    Another question to ask is "what are the odds that predosing with bisantrene 7 days before a cardiotoxic drug will give a worse CP outcome than giving bisantrene at the same time as the cardiotoxic drug?"
    i.e. is there a lag in the CP MOA?

    Hold, Held
    Last edited by IndexInvestor: 30/07/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.